A case of pulmonary hemorrhage due to drug-induced pneumonitis secondary to ticagrelor therapy

T.J. Whitmore; J.P. O'Shea; D. Starac; M.G. Edwards; Grant Waterer

doi:10.1378/chest.13-1502

A case of pulmonary hemorrhage due to drug-induced pneumonitis secondary to ticagrelor therapy

T.J. Whitmore, J.P. O'Shea, D. Starac, M.G. Edwards, Grant Waterer

Graduate Research School

Research output: Contribution to journal › Article › peer-review

14 Citations (Scopus)

Abstract

We report a case of significant pulmonary hemorrhage developing shortly after commencing ticagrelor and aspirin therapy and requiring coronary artery bypass grafting to safely cease the antiplatelet therapy. Lung biopsy fi ndings were consistent with druginduced lung injury. Clinicians should be aware of this significant adverse event with this drug class. © 2014 American College of Chest Physicians.

Original language	English
Pages (from-to)	639-641
Journal	Chest
Volume	145
Issue number	3
DOIs	https://doi.org/10.1378/chest.13-1502
Publication status	Published - 2014

Access to Document

10.1378/chest.13-1502

Cite this

@article{f03752274cba46dd9af3be19455973a5,

title = "A case of pulmonary hemorrhage due to drug-induced pneumonitis secondary to ticagrelor therapy",

abstract = "We report a case of significant pulmonary hemorrhage developing shortly after commencing ticagrelor and aspirin therapy and requiring coronary artery bypass grafting to safely cease the antiplatelet therapy. Lung biopsy fi ndings were consistent with druginduced lung injury. Clinicians should be aware of this significant adverse event with this drug class. {\textcopyright} 2014 American College of Chest Physicians.",

author = "T.J. Whitmore and J.P. O'Shea and D. Starac and M.G. Edwards and Grant Waterer",

year = "2014",

doi = "10.1378/chest.13-1502",

language = "English",

volume = "145",

pages = "639--641",

journal = "Chest: the cardiopulmonary and critical care journal",

issn = "0012-3692",

publisher = "Elsevier",

number = "3",

}

TY - JOUR

T1 - A case of pulmonary hemorrhage due to drug-induced pneumonitis secondary to ticagrelor therapy

AU - Whitmore, T.J.

AU - O'Shea, J.P.

AU - Starac, D.

AU - Edwards, M.G.

AU - Waterer, Grant

PY - 2014

Y1 - 2014

N2 - We report a case of significant pulmonary hemorrhage developing shortly after commencing ticagrelor and aspirin therapy and requiring coronary artery bypass grafting to safely cease the antiplatelet therapy. Lung biopsy fi ndings were consistent with druginduced lung injury. Clinicians should be aware of this significant adverse event with this drug class. © 2014 American College of Chest Physicians.

AB - We report a case of significant pulmonary hemorrhage developing shortly after commencing ticagrelor and aspirin therapy and requiring coronary artery bypass grafting to safely cease the antiplatelet therapy. Lung biopsy fi ndings were consistent with druginduced lung injury. Clinicians should be aware of this significant adverse event with this drug class. © 2014 American College of Chest Physicians.

U2 - 10.1378/chest.13-1502

DO - 10.1378/chest.13-1502

M3 - Article

C2 - 24590025

VL - 145

SP - 639

EP - 641

JO - Chest: the cardiopulmonary and critical care journal

JF - Chest: the cardiopulmonary and critical care journal

SN - 0012-3692

IS - 3

ER -

A case of pulmonary hemorrhage due to drug-induced pneumonitis secondary to ticagrelor therapy

Abstract

Access to Document

Fingerprint

Cite this